Award recordCONTRACT

LUNDBECK LLC

PIID 36C26018N0097· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $77,964 net obligations· UEI F1M3L99R99B3· IL

Description

DROXIDOPA NORTHRA 300MG ORAL CAPSULES NDC 67386-0822-19

First action · last action
2017-11-13 · 2020-05-19
Transactions
3
First transaction's obligation
$75,981
Base + all options value (sum of deltas)
$77,964
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P14A0003
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$120,303$0Base award · 2017-11-13 · this action $75,981 · running total $75,981Modification P00001 · 2018-06-27 · this action $44,322 · running total $120,303Modification P00002 · 2020-05-19 · this action -$42,339 · running total $77,964
  • Base2017-11-13+$75,981= $75,981
  • Mod P000012018-06-27+$44,322= $120,303
  • Mod P000022020-05-19-$42,339= $77,964
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-11-13+$75,981$75,981DROXIDOPA NORTHRA 300MG ORAL CAPSULES NDC 67386-0822-19
Mod P00001· FUNDING ONLY ACTION2018-06-27+$44,322$120,303DROXIDOPA NORTHRA 300MG ORAL CAPSULES NDC 67386-0822-19
Mod P00002· FUNDING ONLY ACTION2020-05-19−$42,339$77,964DROXIDOPA NORTHRA 300MG ORAL CAPSULES NDC 67386-0822-19

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI F1M3L99R99B3)

AwardOffice · PSC / listingNet obligationsFY
36F79726D0172NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C24920N0537249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$25,476FY2020
36C24920N0520249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$20,381FY2020
36C24920N0515249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$10,191FY2020
36C24920N0502249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$10,191FY2020
36C24920N0482249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$10,191FY2020

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26018N0097_3600_VA797P14A0003_3600 · retrieved 2026-09-26.